Save your place

Sign in to WhoBought

Please try again later.

Joel Greenblatt's Elevance Health Inc. (ELV) position

Yes: as of Q1 2026, Joel Greenblatt holds 40K shares of ELV worth $12M (0.0% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
$12M
Shares held
40K
% of portfolio
0.0%
Est. average buy price (i)
$381.47
est. since Q1 2021
Quarter-end price
$292.75

Estimated trade prices

Average price in quarters with purchases
$390.96
Average prices in quarters with sales
  • Q1 2026: $328.64 (73K shares sold)
  • Q4 2025: $338.05 (5K shares sold)
  • Q2 2025: $402.22 (11K shares sold)
  • Q1 2024: $497.33 (7K shares sold)
  • Q4 2022: $507.74 (14K shares sold)
  • Q3 2022: $478.49 (2K shares sold)
  • Q2 2022: $494.71 (3K shares sold)
  • Q1 2022: $457.10 (3K shares sold)
  • Q3 2021: $380.04 (685 shares sold)

ELV price vs Greenblatt's position

1Y 3Y 5Y MAX
Dates
$200$400$60020222023202420252026Sold 685 shares (3.4%) · Q3 2021. Average closing price $380.04 · Price range $357.51–$398.13685sharessoldAdded 9K shares (47.1%) · Q4 2021. Average closing price $420.70 · Price range $370.08–$467.679KsharespurchasedSold 3K shares (9.2%) · Q1 2022. Average closing price $457.10 · Price range $428.44–$502.483KsharessoldSold 3K shares (11.9%) · Q2 2022. Average closing price $494.71 · Price range $444.32–$529.843KsharessoldSold 2K shares (8.8%) · Q3 2022. Average closing price $478.49 · Price range $445.98–$507.002KsharessoldSold 14K shares (69.9%) · Q4 2022. Average closing price $507.74 · Price range $465.23–$546.7714KsharessoldAdded 303 shares (4.9%) · Q1 2023. Average closing price $475.89 · Price range $446.30–$502.20303sharespurchasedAdded 1K shares (16.0%) · Q2 2023. Average closing price $461.32 · Price range $436.33–$496.201KsharespurchasedAdded 3K shares (33.8%) · Q3 2023. Average closing price $453.58 · Price range $414.13–$475.933KsharespurchasedAdded 415 shares (4.1%) · Q4 2023. Average closing price $462.41 · Price range $433.51–$488.06415sharespurchasedSold 7K shares (64.0%) · Q1 2024. Average closing price $497.33 · Price range $464.61–$519.967KsharessoldAdded 8K shares (211.7%) · Q2 2024. Average closing price $528.58 · Price range $497.49–$547.808KsharespurchasedAdded 15K shares (125.6%) · Q3 2024. Average closing price $534.22 · Price range $500.12–$562.2915KsharespurchasedAdded 27K shares (101.4%) · Q4 2024. Average closing price $418.46 · Price range $365.96–$511.2627KsharespurchasedAdded 17K shares (31.8%) · Q1 2025. Average closing price $401.43 · Price range $365.83–$436.2517KsharespurchasedSold 11K shares (16.1%) · Q2 2025. Average closing price $402.22 · Price range $372.27–$452.6911KsharessoldAdded 58K shares (97.9%) · Q3 2025. Average closing price $311.02 · Price range $274.66–$395.7658KsharespurchasedSold 5K shares (4.0%) · Q4 2025. Average closing price $338.05 · Price range $303.78–$362.345KsharessoldSold 73K shares (64.7%) · Q1 2026. Average closing price $328.64 · Price range $280.74–$381.9373Ksharessold← Earlier —1 purchase
Average closing price · filing quarter
$328.64
Price range · filing quarter
$280.74 – $381.93
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Reduced −73K −$24M −64.7% 40K May 15, 2026
Q4 2025 Reduced −5K −$1.6M −4.0% 113K Feb 17, 2026
Q3 2025 Added +58K +$18M +97.9% 117K Nov 14, 2025
Q2 2025 Reduced −11K −$4.6M −16.1% 59K Aug 14, 2025
Q1 2025 Added +17K +$6.8M +31.8% 71K May 15, 2025
Q4 2024 Added +27K +$11M +101.4% 54K Feb 14, 2025
Q3 2024 Added +15K +$7.9M +125.6% 27K Nov 14, 2024
Q2 2024 Added +8K +$4.2M +211.7% 12K Aug 14, 2024
Q1 2024 Reduced −7K −$3.3M −64.0% 4K May 15, 2024
Q4 2023 Added +415 +$192K +4.1% 11K Feb 14, 2024
Q3 2023 Added +3K +$1.2M +33.8% 10K Nov 14, 2023
Q2 2023 Added +1K +$479K +16.0% 8K Aug 14, 2023
Q1 2023 Added +303 +$144K +4.9% 7K May 15, 2023
Q4 2022 Reduced −14K −$7.3M −69.9% 6K Feb 14, 2023
Q3 2022 Reduced −2K −$958K −8.8% 21K Nov 14, 2022
Q2 2022 Reduced −3K −$1.5M −11.9% 23K Aug 15, 2022
Q1 2022 Reduced −3K −$1.2M −9.2% 26K May 16, 2022
Q4 2021 Added +9K +$3.8M +47.1% 28K Feb 14, 2022
Q3 2021 Reduced −685 −$260K −3.4% 19K Nov 15, 2021
Q2 2021 Added +8K +$2.9M +62.2% 20K Aug 16, 2021
Q1 2021 First covered – – – 12K May 17, 2021
Data through Q1 2026 · filed May 15, 2026
21 grouped rows from 21 quarters

Who else owns ELV

Wellington Management Group LLP
owns 3.8% of shares outstanding
Est. $2.4B · Shares: 8.2M

Sanders Capital, LLC
owns 2.7% of shares outstanding
Est. $1.7B · Shares: 5.9M

Artisan Partners Limited Partnership
owns 2.4% of shares outstanding
Est. $1.5B · Shares: 5.1M

Invesco Ltd.

 View investor →
owns 2.2% of shares outstanding
Est. $1.4B · Shares: 4.8M

See all owners of ELV →

More Greenblatt positions

Apple Inc.(AAPL)
$727M
2.2% of portfolio

NVIDIA Corporation(NVDA)
$715M
2.2% of portfolio

Amazon.com, Inc.(AMZN)
$163M
0.5% of portfolio

Alphabet Inc.(GOOGL)
$155M
0.5% of portfolio

Snowflake Inc.(SNOW)
$150M
0.5% of portfolio

Common questions

Does Joel Greenblatt own ELV?

Yes. As of Q1 2026, Joel Greenblatt disclosed 40K shares of ELV, worth $12M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Joel Greenblatt buy ELV?

Joel Greenblatt held ELV since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Joel Greenblatt sell ELV?

The quarter-by-quarter table above shows each sale and reduction Joel Greenblatt disclosed in ELV. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of ELV does Joel Greenblatt own?

Joel Greenblatt disclosed 40K shares of ELV as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Joel Greenblatt pay for ELV?

Joel Greenblatt began building the ELV position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.